Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2025, Johnson & Johnson reported revenue of $94.19B, up 6.0% year over year. Operating margin was n/a and net margin 28.5%, on a free-cash-flow margin of 20.9% with capital expenditure at 5.1% of revenue. Every figure is computed directly from JNJ's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $94.19B | n/a | 28.5% |
| FY2024 | $88.82B | n/a | 15.8% |
| FY2023 | $85.16B | n/a | 41.3% |
| FY2022 | $79.99B | n/a | 22.4% |
| FY2021 | $78.74B | n/a | 26.5% |
How does JNJ compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.